Estudo randomizado | Dois cursos vs. três cursos de cisplatina pré-cirúrgica e fluorouracila com docetaxel para carcinoma esofágico de células escamosas avançado.
22 Fev, 2022 | 14:22hMulticenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma – British Journal of Cancer (link para o resumo – leia grátis aqui)
Comentário no Twitter
Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma
Read for free: https://t.co/vXRAP29FRo#Chemotherapy #Cancer pic.twitter.com/D7KBifTFOS
— British Journal of Cancer (@BrJCancer) February 9, 2022


